 Iovance Biotherapeutics, Inc. NASDAQ:IOVA Q1 2022 Results Conference Call May 5, 2022 4:30 PM ET Company Participants Sara Pellegrino - Vice President, Investor and Public Relations Dr. Fred Vogt - Interim President and Chief Executive Officer Dr. Igor Bilinsky - Chief Operating Officer Jim Ziegler - Senior Vice President, Commercial Dr. Friedrich Finckenstein - Chief Medical Officer Dr. Madan Jagasia - Senior Vice President, Medical Affairs Jean-Marc Bellemin - Chief Financial Officer Dr. Raj Puri - Executive Vice President, Regulatory Strategy and Translational Medicine Conference Call Participants Madhu Kumar - Goldman Sachs Peter Lawson - Barclays Colleen Kusy - Baird Tyler Van Buren - Cowen Mark Breidenbach - Oppenheimer Ben Burnett - Stifel Reni Benjamin - JMP Securities Operator Welcome to the Iovance Biotherapeutics First Quarter 2022 Financial Results. My name is Andrew, and I will be your operator for todays call. 